iRhythm Technologies (IRTC) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces ...

Looking back on patient monitoring stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including iRhythm (NASDAQ:IRTC) and its peers. Patient monitoring companies within ...

IRhythm Technologies (IRTC) came out with quarterly earnings of $0.01 per share, beating the Zacks Consensus Estimate of a loss of $0.30 per share. This compares to loss of $1.26 per share a year ago.

Medical technology company iRhythm Technologies (NASDAQ:IRTC) reported Q4 CY2024 results , with sales up 24% year on year to $164.3 million. The company expects the full year’s revenue to be ...

Short interest in iRhythm Technologies Inc (NASDAQ:IRTC) increased during the last reporting period, rising from 2.42M to 2.63M. This put 8.4% of the company's publicly available shares short.